株探米国株
日本語 英語
エドガーで原本を確認する
0001516513FALSE00015165132023-02-092023-02-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________________________________________________________________________________________________
FORM 8-K
_________________________________________________________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 9, 2023
_________________________________________________________________________________________________________________
Doximity, Inc.
(Exact Name of Registrant as Specified in Its Charter)
_________________________________________________________________________________________________________________
Delaware 001-40508 27-2485512
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification Number)
500 3rd St.
Suite 510
San Francisco, CA 94107
(Address of principal executive offices, including zip code)
(650) 549-4330
(Registrant's telephone number, including area code)
_______________________________________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Class A common stock, $0.001 par value per share DOCS The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02 – Results of Operations and Financial Condition
On February 9, 2023, Doximity, Inc. (“Doximity”) issued a press release announcing its financial results for its fiscal quarter ended December 31, 2022. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.
The information provided in this Item 2.02 of this Current Report on Form 8-K, and the Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 – Financial Statements and Exhibits
(d) Exhibits
Exhibit Number Description
99.1
104 Cover Page Interactive Data File (embedded within the inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 9, 2023
DOXIMITY, INC.
By:
/s/ Anna Bryson
Anna Bryson
Chief Financial Officer


EX-99.1 2 doximity-20221231xex991.htm EX-99.1 Document

Exhibit 99.1
Doximity Announces Fiscal 2023 Third Quarter Financial Results
Total revenues of $115.3 million, up 18% year-over-year
Operating cash flow of $48.7 million, up 78% year-over-year
Free cash flow of $47.5 million, up 85% year-over-year

SAN FRANCISCO, Calif., February 9, 2023 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results for the fiscal 2023 third quarter ended December 31, 2022.
“Our clinical workflow tools saw record use last quarter, including our telehealth platform which served 375,000 unique active clinicians,” said Jeff Tangney, co-founder and CEO at Doximity. “We’re proud to help more physicians be more mobile and more productive than ever before.”
Fiscal 2023 Third Quarter Financial Highlights
All comparisons, unless otherwise noted, are to the three months ended December 31, 2021.
•Revenue: Revenue of $115.3 million, versus $97.9 million, an increase of 18% year-over-year.
•Net income and non-GAAP net income: Net income of $33.5 million, versus $55.6 million, representing a margin of 29.0%, versus 56.9%. Non-GAAP net income of $45.8 million, versus $63.6 million, representing a margin of 39.7%, versus 65.0%.
•Adjusted EBITDA: Adjusted EBITDA of $55.5 million, versus $47.0 million, an increase of 18% year-over-year, representing adjusted EBITDA margins of 48.2%, versus 48.0%.
•Net income per share and non-GAAP net income per share: Diluted net income per share was $0.16, versus $0.26, while non-GAAP diluted net income per share was $0.22, versus $0.29.
•Operating cash flow and free cash flow: Operating cash flow of $48.7 million, versus $27.3 million, an increase of 78% year-over-year, and free cash flow of $47.5 million, versus $25.6 million, an increase of 85% year-over-year.
Financial Outlook
Doximity is providing guidance for its fiscal fourth quarter ending March 31, 2023 as follows:
•Revenue between $109.6 million and $110.6 million.
•Adjusted EBITDA between $45.2 million and $46.2 million.
Doximity is adjusting its guidance for its fiscal year ending March 31, 2023 as follows:
•Revenue between $417.7 million and $418.7 million.
•Adjusted EBITDA between $180.2 million and $181.2 million.
Doximity is providing preliminary guidance for its fiscal year ending March 31, 2024 as follows:
•Revenue of greater than $500 million.
•Adjusted EBITDA margin of 43% or greater.

1


Conference Call Information
Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The Company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients. For more information, visit www.doximity.com.
Forward-Looking Statements
Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of the COVID-19 pandemic (including the impact to our industry or on our customers’ industries, impact on general economic conditions, and government responses, restrictions, and actions related to the pandemic); (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in the Annual Report on Form 10-K that was filed with the SEC on May 27, 2022. Additional information will be provided in our Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2022. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Investor Relations Contact:
Perry Gold
ir@doximity.com
Media Contact:
Amanda Cox
pr@doximity.com




2


DOXIMITY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
December 31, 2022 March 31, 2022
Assets
Current assets:
Cash and cash equivalents $ 136,454  $ 112,809 
Marketable securities 664,511  685,304 
Accounts receivable, net 74,862  81,073 
Prepaid expenses and other current assets 17,120  19,439 
Deferred contract costs, current 5,572  5,512 
Total current assets 898,519  904,137 
Property and equipment, net 11,519  8,488 
Deferred income tax assets 40,338  48,558 
Operating lease right-of-use assets 14,357  1,087 
Intangible assets, net 33,034  7,909 
Goodwill 67,940  18,915 
Other assets 1,380  2,263 
Total assets $ 1,067,087  $ 991,357 
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable $ 1,604  $ 463 
Accrued expenses and other current liabilities 33,151  25,270 
Deferred revenue, current 69,671  84,907 
Operating lease liabilities, current 1,458  642 
Total current liabilities 105,884  111,282 
Deferred revenue, non-current 140  78 
Operating lease liabilities, non-current 14,181  447 
Contingent earn-out consideration liability, non-current 15,625  — 
Other liabilities, non-current 1,083  956 
Total liabilities 136,913  112,763 
Stockholders' Equity
Preferred stock —  — 
Common stock 193  192 
Additional paid-in capital 745,506  702,589 
Accumulated other comprehensive loss (18,742) (15,294)
Retained earnings 203,217  191,107 
Total stockholders' equity 930,174  878,594 
Total liabilities and stockholders’ equity $ 1,067,087  $ 991,357 

3


DOXIMITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended December 31, Nine Months Ended December 31,
2022 2021 2022 2021
Revenue $ 115,262  $ 97,876  $ 308,086  $ 249,895 
Cost of revenue(1)
13,526  11,085  39,813  28,022 
Gross profit 101,736  86,791  268,273  221,873 
Operating expenses(1):
Research and development 20,519  16,225  58,645  44,926 
Sales and marketing 33,220  25,698  90,375  66,230 
General and administrative 9,513  9,079  26,986  25,102 
Total operating expenses 63,252  51,002  176,006  136,258 
Income from operations 38,484  35,789  92,267  85,615 
Other income, net 2,461  20  4,173  485 
Income before income taxes 40,945  35,809  96,440  86,100 
Provision for (benefit from) income taxes 7,477  (19,838) 14,290  (31,957)
Net income $ 33,468  $ 55,647  $ 82,150  $ 118,057 
Undistributed earnings attributable to participating securities —  —  —  (21,866)
Net income attributable to Class A and Class B common stockholders, basic and diluted $ 33,468  $ 55,647  $ 82,150  $ 96,191 
Net income per share attributable to Class A and Class B common stockholders:
Basic $ 0.17  $ 0.30  $ 0.43  $ 0.62 
Diluted $ 0.16  $ 0.26  $ 0.38  $ 0.53 
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic 192,805  188,372  192,963  154,289 
Diluted 212,065  216,396  213,656  182,905 
(1) Costs and expenses include stock-based compensation expense as follows (in thousands):
Three Months Ended December 31, Nine Months Ended December 31,
2022 2021 2022 2021
Cost of revenue $ 2,695  $ 1,912  $ 7,209  $ 2,973 
Research and development 4,002  2,035  9,416  4,864 
Sales and marketing 4,856  2,681  11,912  5,575 
General and administrative 2,431  3,206  6,306  8,221 
Total stock-based compensation expense $ 13,984  $ 9,834  $ 34,843  $ 21,633 
4


DOXIMITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Three Months Ended December 31, Nine Months Ended December 31,
2022 2021 2022 2021
Cash flows from operating activities
Net income $ 33,468  $ 55,647  $ 82,150  $ 118,057 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 2,616  1,361  7,575  3,672 
Deferred income taxes 9,287  (31,972) 9,392  (31,972)
Stock-based compensation, net of amounts capitalized 13,984  9,834  34,843  21,633 
Non-cash lease expense 538  288  1,490  857 
Amortization of premium on marketable securities, net 471  1,302  3,144  2,863 
Loss on sale of marketable securities 593  595  1,093  525 
Amortization of deferred contract costs 1,518  1,710  6,357  7,366 
Other 790  (73) 797  120 
Changes in operating assets and liabilities, net of effect of acquisition:
Accounts receivable 3,997  (14,021) 6,191  (19,579)
Prepaid expenses and other assets (1,727) 10,722  1,924  (7,003)
Deferred contract costs (4,067) (3,697) (6,409) (6,672)
Accounts payable, accrued expenses and other liabilities 7,197  8,872  2,723  8,093 
Deferred revenue (19,970) (13,111) (18,098) (17,538)
Operating lease liabilities (173) (209) (811)
Net cash provided by operating activities 48,697  27,284  132,963  79,611 
Cash flows from investing activities
Cash paid for acquisition —  —  (53,500) — 
Purchases of property and equipment (204) (611) (1,680) (852)
Internal-use software development costs (1,012) (1,065) (3,478) (2,736)
Purchases of marketable securities (39,080) (115,772) (130,257) (1,271,915)
Maturities of marketable securities 10,576  6,066  35,014  41,617 
Sales of marketable securities 43,024  85,862  107,182  616,938 
Net cash provided by (used in) investing activities 13,304  (25,520) (46,719) (616,948)
Cash flows from financing activities
Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions —  —  —  553,905 
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants 1,871  4,174  7,455  9,234 
Proceeds from issuance of common stock in connection with the employee stock purchase plan —  —  2,341  — 
Taxes paid related to net share settlement of equity awards (1,092) (380) (2,353) (436)
Repurchase of common stock —  —  (70,042) (2,698)
Payments of deferred offering costs —  —  —  (3,982)
Net cash provided by (used in) financing activities 779  3,794  (62,599) 556,023 
Net increase in cash and cash equivalents 62,780  5,558  23,645  18,686 
Cash and cash equivalents, beginning of period 73,674  79,521  112,809  66,393 
Cash and cash equivalents, end of period
$ 136,454  $ 85,079  $ 136,454  $ 85,079 

5


Non-GAAP Financial Measures
To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:
•Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of stock-based compensation expense, amortization of acquired intangible assets, change in fair value of contingent earn-out consideration liability, and expenses associated with acquisitions from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net income margin are further adjusted for estimated income tax on such adjustments. We calculate income taxes on the adjustments by applying an estimated annual effective tax rate to the adjustments. Non-GAAP basic and diluted net income per common share is non-GAAP net income attributable to common stockholders divided by the weighted average number of shares. For both basic and diluted non-GAAP net income per share, the weighted average shares we use in computing non-GAAP net income per share is equal to our GAAP weighted average shares. Non-GAAP gross margin represents non-GAAP gross profit as a percentage of revenue and non-GAAP net income margin represents non-GAAP net income as a percentage of revenue.
•Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for acquisition and other related expenses, stock-based compensation expense, change in fair value of contingent earn-out consideration liability, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.
•Free cash flow: We calculate free cash flow as cash flow from operating activities less purchases of property and equipment and internal-use software development costs.
We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.
Key Business Metrics1
•Net revenue retention rate: Net revenue retention rate is calculated by taking the trailing 12-month (“TTM”) subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn. Our net revenue retention rate is directly tied to our revenue growth rate and thus fluctuates as that growth rate fluctuates.
•Customers with trailing 12-month subscription revenue greater than $100,000: The number of customers with TTM subscription revenue greater than $100,000 is a key indicator of the scale of our business, and is calculated by counting the number of customers that contributed more than $100,000 in subscription revenue in the TTM period. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity.
1 The metric excludes the impact of the AMiON acquisition, which closed on April 1, 2022, including customers of, and subscription revenue generated from, the AMiON on-call scheduling and messaging application and was immaterial to the periods presented.
6


Reconciliation of GAAP to Non-GAAP Financial Measures
The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:
Three Months Ended December 31, Nine Months Ended December 31,
2022 2021 2022 2021
(unaudited)
(in thousands, except percentages)
Net income $ 33,468  $ 55,647  $ 82,150  $ 118,057 
Adjusted to exclude the following:
Acquisition and other related expenses —  —  30  — 
Stock-based compensation 13,984  9,834  34,843  21,633 
Depreciation and amortization 2,616  1,361  7,575  3,672 
Provision for (benefit from) income taxes 7,477  (19,838) 14,290  (31,957)
Change in fair value of contingent earn-out consideration liability 417  —  323  — 
Other income, net (2,461) (20) (4,173) (485)
Adjusted EBITDA $ 55,501  $ 46,984  $ 135,038  $ 110,920 
Revenue $ 115,262  $ 97,876  $ 308,086  $ 249,895 
Net income margin 29.0  % 56.9  % 26.7  % 47.2  %
Adjusted EBITDA margin 48.2  % 48.0  % 43.8  % 44.4  %

Three Months Ended December 31, Nine Months Ended December 31,
2022 2021 2022 2021
(unaudited)
(in thousands)
Net cash provided by operating activities $ 48,697  $ 27,284  $ 132,963  $ 79,611 
Purchases of property and equipment (204) (611) (1,680) (852)
Internal-use software development costs (1,012) (1,065) (3,478) (2,736)
Free cash flow $ 47,481  $ 25,608  $ 127,805  $ 76,023 
Other cash flow components:
Net cash provided by (used in) investing activities $ 13,304  $ (25,520) $ (46,719) $ (616,948)
Net cash provided by (used in) financing activities $ 779  $ 3,794  $ (62,599) $ 556,023 
7


Three Months Ended December 31, Nine Months Ended December 31,
2022 2021 2022 2021
(unaudited)
(in thousands, except per share data and percentages)
GAAP cost of revenue $ 13,526  $ 11,085  $ 39,813  $ 28,022 
Adjusted to exclude the following:
Stock-based compensation (2,695) (1,912) (7,209) (2,973)
Amortization of acquired intangibles (137) —  (410) — 
Non-GAAP cost of revenue $ 10,694  $ 9,173  $ 32,194  $ 25,049 
GAAP gross profit $ 101,736  $ 86,791  $ 268,273  $ 221,873 
Adjusted to exclude the following:
Stock-based compensation 2,695  1,912  7,209  2,973 
Amortization of acquired intangibles 137  —  410  — 
Non-GAAP gross profit $ 104,568  $ 88,703  $ 275,892  $ 224,846 
GAAP gross margin 88.3  % 88.7  % 87.1  % 88.8  %
Non-GAAP gross margin 90.7  % 90.6  % 89.6  % 90.0  %
GAAP research and development expense $ 20,519  $ 16,225  $ 58,645  $ 44,926 
Adjusted to exclude the following:
Stock-based compensation (4,002) (2,035) (9,416) (4,864)
Non-GAAP research and development expense $ 16,517  $ 14,190  $ 49,229  $ 40,062 
GAAP sales and marketing expense $ 33,220  $ 25,698  $ 90,375  $ 66,230 
Adjusted to exclude the following:
Stock-based compensation (4,856) (2,681) (11,912) (5,575)
Amortization of acquired intangibles (1,061) (265) (3,185) (795)
Change in fair value of contingent earn-out consideration liability (417) —  (323) — 
Non-GAAP sales and marketing expense $ 26,886  $ 22,752  $ 74,955  $ 59,860 
GAAP general and administrative expense $ 9,513  $ 9,079  $ 26,986  $ 25,102 
Adjusted to exclude the following:
Acquisition and other related expenses —  —  (30) — 
Stock-based compensation (2,431) (3,206) (6,306) (8,221)
Non-GAAP general and administrative expense $ 7,082  $ 5,873  $ 20,650  $ 16,881 
GAAP operating expense $ 63,252  $ 51,002  $ 176,006  $ 136,258 
Adjusted to exclude the following:
Acquisition and other related expenses —  —  (30) — 
Stock-based compensation (11,289) (7,922) (27,634) (18,660)
Amortization of acquired intangibles (1,061) (265) (3,185) (795)
Change in fair value of contingent earn-out consideration liability (417) —  (323) — 
Non-GAAP operating expense $ 50,485  $ 42,815  $ 144,834  $ 116,803 
8


Three Months Ended December 31, Nine Months Ended December 31,
2022 2021 2022 2021
(unaudited)
(in thousands, except per share data and percentages)
GAAP operating income $ 38,484  $ 35,789  $ 92,267  $ 85,615 
Adjusted to exclude the following:
Acquisition and other related expenses —  —  30  — 
Stock-based compensation 13,984  9,834  34,843  21,633 
Amortization of acquired intangibles 1,198  265  3,595  795 
Change in fair value of contingent earn-out consideration liability 417  —  323  — 
Non-GAAP operating income $ 54,083  $ 45,888  $ 131,058  $ 108,043 
GAAP net income $ 33,468  $ 55,647  $ 82,150  $ 118,057 
Adjusted to exclude the following:
Acquisition and other related expenses —  —  30  — 
Stock-based compensation 13,984  9,834  34,843  21,633 
Amortization of acquired intangibles 1,198  265  3,595  795 
Change in fair value of contingent earn-out consideration liability 417  —  323  — 
Income tax effect of non-GAAP adjustments (1)
(3,276) (2,121) (8,146) (4,710)
Non-GAAP net income $ 45,791  $ 63,625  $ 112,795  $ 135,775 
Non-GAAP net income margin 39.7  % 65.0  % 36.6  % 54.3  %
GAAP undistributed earnings attributable to participating securities $ —  $ —  $ —  $ (21,866)
Impact on undistributed earnings attributable to participating securities due to non-GAAP adjustments —  —  —  (2,436)
Non-GAAP undistributed earnings attributable to participating securities $ —  $ —  $ —  $ (24,302)
Non-GAAP net income $ 45,791  $ 63,625  $ 112,795  $ 135,775 
Non-GAAP undistributed earnings attributable to participating securities —  —  —  (24,302)
Non-GAAP net income attributable to Class A and Class B stockholders, basic and diluted $ 45,791  $ 63,625  $ 112,795  $ 111,473 
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic 192,805  188,372  192,963  154,289 
Diluted 212,065  216,396  213,656  182,905 
Non-GAAP net income per share attributable to Class A and Class B stockholders:
Basic $ 0.24  $ 0.34  $ 0.58  $ 0.72 
Diluted $ 0.22  $ 0.29  $ 0.53  $ 0.61 
(1) For the three and nine months ended December 31, 2022 and 2021, management used an estimated annual effective non-GAAP tax rate of 21.0%.
9